SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Vaccinia immune globulin



    Most People Believe Smallpox Not An Extinct Disease, Survey Shows  Apr 1, 2008
    31, 2008) The vast majority of Scottish people interviewed in the streets of Edinburgh are unaware of one of the greatest achievements of medical science -- the eradication of smallpox from the world over 40 years ago. A poll sponsored by the Society for General Microbiology (SGM), in conjunction with the Edinburgh International Science Festival, has revealed that 87% of 200 individuals questioned did not know that the horrendous, killer disease is now extinct. (Science Daily)

    Female Plasma May Not Be As Harmful As Once Thought  Oct 25, 2007
    3, 2005) The U.S. Food and Drug Administration has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of. (Aug. (Science Daily)

    CDC pays for jets it rarely uses  May 28, 2007
    A jet made three round trips carrying vaccinia immune globulin to treat a 2-year-old Indiana boy who suffered a life-threatening viral infection contracted from the smallpox vaccination his military father received before going to Iraq. Skinner said that the stockpiled medicine is such a precious commodity that the agency only took one dose per trip. (Atlanta Journal-Constitution)

    FDA Approves Cangene's Hepagam B For A Second Indication  Apr 10, 2007
    Cangene manufactures HepaGam B in its Winnipeg facility using a process similar to that of WinRho(R) SDF, Vaccinia Immune Globulin and VariZIG, the Company's other hyperimmune products that have been approved in Canada and/or the United States. A vaccine for hepatitis B is available, yet the virus continues to cause significant disease worldwide and pose a significant public health problem. (Playfuls.com)

    FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients  Apr 7, 2007
    Cangene manufactures HepaGam B(TM) in its Winnipeg facility using a process similar to that of WinRho(R) SDF, Vaccinia Immune Globulin and VariZIG(TM), the Company's other hyperimmune products that have been approved in Canada and/or the United States. A vaccine for hepatitis B is available, yet the virus continues to cause significant disease worldwide and pose a significant public health problem. (PR Newswire)

    New Test May Allow For Rapid Detection Of Smallpox Virus  Dec 14, 2006
    Researchers from Spain have developed a new test that may rapidly detect the variola virus, the etiological agent of smallpox, as well as differentiate it from other orthopoxviruses while avoiding false-negative results. Their findings appear in the December 2006 issue of the Journal of Clinical Microbiology. (Science Daily)




    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2008